Loading...

Regeneus Ltd

RGS.AX•ASX
Healthcare
Biotechnology
A$0.01
A$0.003(33.33%)

Regeneus Ltd (RGS.AX) Stock Overview

Explore Regeneus Ltd’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap3.7M
P/E Ratio-2.18
EPS (TTM)$-0.01
ROE4.56%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

RGS.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Regeneus Ltd (RGS.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.18 and a market capitalization of 3.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for RGS.AXStats details for RGS.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for RGS.AXAnalyst Recommendations details for RGS.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. Its lead platform technology includes Progenza, a multi-synergistic therapy for the treatment of osteoarthritis and neuropathic pain. The company also develops Sygenus for the treatment of skin wound healing. Regeneus Ltd was incorporated in 2007 and is headquartered in Paddington, Australia.

CEO

Karolis Rosickas

Headquarters

2 Paddington Street, Paddington, NSW

Founded

2013

Frequently Asked Questions

;